Market Cap 185.13M
Revenue (ttm) 67.64M
Net Income (ttm) -116.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -171.57%
Debt to Equity Ratio 0.00
Volume 223,700
Avg Vol 167,478
Day's Range N/A - N/A
Shares Out 21.38M
Stochastic %K 4%
Beta 0.84
Analysts Strong Sell
Price Target $17.67

Company Profile

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 607 0800
Fax: 617 607 0530
Address:
4 Kingsbury Avenue, Watertown, United States
Raxothus
Raxothus Sep. 3 at 5:09 PM
EOD CONTINUATION FOLLOW-UP – 09/03/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $ACIU – Closed 2.20, HOD 2.32 (+5.5%). Small continuation but failed VWAP hold. ✅ $RNXT – Closed 1.08, HOD 1.25 (+15.7%). Solid push, circling VWAP 1.19. Valid continuation. ❌ $ENTA – Closed 9.03, down today, no continuation. Off watch. ✅ $CCG – Closed 1.10, HOD 1.28 (+16.3%). Decent move, holding near VWAP 1.20. ❌ $MATH – Closed 3.28, down today, no continuation. Off watch. Recap: 5 total → 3 winners, 2 fails → 60% accuracy Leaders: $RNXT (+15.7%) and $CCG (+16.3%) gave the cleanest continuation moves. $ACIU (+5.5%) weaker but still valid early push. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 7:03 AM
$ENTA Excellent article that nails exactly where ENTA stands right now. So if you want to update your ENTA knowledge or get acquainted with ENTA, this is a must read. https://beyondspx.com/quote/ENTA/enanta-pharmaceuticals-a-biotech-s-bold-pivot-to-proprietary-innovation-nasdaq-enta#analysis
0 · Reply
Raxothus
Raxothus Sep. 2 at 7:26 PM
EOD CONTINUATION WATCHLIST – 09/02/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $ACIU – 2.9x volume, 3.2% VWAP stretch, small float (39.9M). 6.0% open-to-current with 0.0% late push, RSI 43.6. Needs breakout over 2.25 for continuation. $RNXT – 2.3x volume, 1.0% VWAP stretch, small float (30.0M). 8.3% open-to-current with –1.0% late pull, RSI 46.5. Needs reclaim > 1.06 to reset momentum. $ENTA – 2.0x volume, 1.1% VWAP stretch, small float (14.2M). 4.1% open-to-current with 1.0% late push, RSI 47.1. Needs breakout over 9.17 for continuation. $CCG – 4.5x volume, 6.1% VWAP stretch, small float (23.0M). 23.3% open-to-current with 1.9% late push, RSI 44.5. Strong candidate, watching breakout > 1.15. $MATH – 2.4x volume, 1.8% VWAP stretch, small float (17.5M). 14.6% open-to-current with 0.6% late push, RSI 54.5. Needs breakout over 3.35 for continuation. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups #PowerHourWatch
0 · Reply
DARKP00L
DARKP00L Sep. 2 at 12:04 PM
$ENTA 07:26 on Sep. 02 2025 WestPark Capital Initiates Coverage On Enanta Pharma with Buy Rating, Announces Price Target of $24 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Sep. 2 at 11:30 AM
WestPark Capital has updated their rating for Enanta Pharma ( $ENTA ) to Buy with a price target of 24.
0 · Reply
AuctionMarketIQ
AuctionMarketIQ Aug. 23 at 1:28 PM
$ENTA Enanta Pharmaceuticals Inc is facing antiviral drug competition and pipeline challenges
0 · Reply
twogloves
twogloves Aug. 21 at 1:27 PM
$ENTA Up over 16% in a week. What's going on here? I'm not complaining though
0 · Reply
justiceforb_85
justiceforb_85 Aug. 20 at 2:41 AM
$ENTA BARDA funding for their RSV anti-viral would be amazing.
0 · Reply
Estimize
Estimize Aug. 19 at 8:00 PM
Wall St is expecting -1.02 EPS for $ENTA Q4 [Reporting 11/17 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=eps&utm_c
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:03 PM
JMP Securities updates rating for Enanta Pharma ( $ENTA ) to Market Outperform, target set at 24 → 25.
0 · Reply
Latest News on ENTA
Raxothus
Raxothus Sep. 3 at 5:09 PM
EOD CONTINUATION FOLLOW-UP – 09/03/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $ACIU – Closed 2.20, HOD 2.32 (+5.5%). Small continuation but failed VWAP hold. ✅ $RNXT – Closed 1.08, HOD 1.25 (+15.7%). Solid push, circling VWAP 1.19. Valid continuation. ❌ $ENTA – Closed 9.03, down today, no continuation. Off watch. ✅ $CCG – Closed 1.10, HOD 1.28 (+16.3%). Decent move, holding near VWAP 1.20. ❌ $MATH – Closed 3.28, down today, no continuation. Off watch. Recap: 5 total → 3 winners, 2 fails → 60% accuracy Leaders: $RNXT (+15.7%) and $CCG (+16.3%) gave the cleanest continuation moves. $ACIU (+5.5%) weaker but still valid early push. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 7:03 AM
$ENTA Excellent article that nails exactly where ENTA stands right now. So if you want to update your ENTA knowledge or get acquainted with ENTA, this is a must read. https://beyondspx.com/quote/ENTA/enanta-pharmaceuticals-a-biotech-s-bold-pivot-to-proprietary-innovation-nasdaq-enta#analysis
0 · Reply
Raxothus
Raxothus Sep. 2 at 7:26 PM
EOD CONTINUATION WATCHLIST – 09/02/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $ACIU – 2.9x volume, 3.2% VWAP stretch, small float (39.9M). 6.0% open-to-current with 0.0% late push, RSI 43.6. Needs breakout over 2.25 for continuation. $RNXT – 2.3x volume, 1.0% VWAP stretch, small float (30.0M). 8.3% open-to-current with –1.0% late pull, RSI 46.5. Needs reclaim > 1.06 to reset momentum. $ENTA – 2.0x volume, 1.1% VWAP stretch, small float (14.2M). 4.1% open-to-current with 1.0% late push, RSI 47.1. Needs breakout over 9.17 for continuation. $CCG – 4.5x volume, 6.1% VWAP stretch, small float (23.0M). 23.3% open-to-current with 1.9% late push, RSI 44.5. Strong candidate, watching breakout > 1.15. $MATH – 2.4x volume, 1.8% VWAP stretch, small float (17.5M). 14.6% open-to-current with 0.6% late push, RSI 54.5. Needs breakout over 3.35 for continuation. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups #PowerHourWatch
0 · Reply
DARKP00L
DARKP00L Sep. 2 at 12:04 PM
$ENTA 07:26 on Sep. 02 2025 WestPark Capital Initiates Coverage On Enanta Pharma with Buy Rating, Announces Price Target of $24 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Sep. 2 at 11:30 AM
WestPark Capital has updated their rating for Enanta Pharma ( $ENTA ) to Buy with a price target of 24.
0 · Reply
AuctionMarketIQ
AuctionMarketIQ Aug. 23 at 1:28 PM
$ENTA Enanta Pharmaceuticals Inc is facing antiviral drug competition and pipeline challenges
0 · Reply
twogloves
twogloves Aug. 21 at 1:27 PM
$ENTA Up over 16% in a week. What's going on here? I'm not complaining though
0 · Reply
justiceforb_85
justiceforb_85 Aug. 20 at 2:41 AM
$ENTA BARDA funding for their RSV anti-viral would be amazing.
0 · Reply
Estimize
Estimize Aug. 19 at 8:00 PM
Wall St is expecting -1.02 EPS for $ENTA Q4 [Reporting 11/17 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=eps&utm_c
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:03 PM
JMP Securities updates rating for Enanta Pharma ( $ENTA ) to Market Outperform, target set at 24 → 25.
0 · Reply
justiceforb_85
justiceforb_85 Aug. 12 at 4:50 AM
$ENTA trading at less than cash on hand when they are furthest along in RSV anti-viral.
1 · Reply
savybull90
savybull90 Aug. 11 at 7:34 PM
$ENTA trash
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 7:37 PM
$ENTA Excellent article that nails exactly where ENTA stands right now. So if you want to update your ENTA knowledge or get acquainted with ENTA, this is a must read. https://beyondspx.com/article/enanta-pharmaceuticals-unlocking-pipeline-value-beyond-hcv-royalties-nasdaq-enta
0 · Reply
JarvisFlow
JarvisFlow Jul. 28 at 11:00 AM
HC Wainwright & Co. has updated their rating for Enanta Pharma ( $ENTA ) to Buy with a price target of 20.
0 · Reply
BNBComedian
BNBComedian Jul. 23 at 2:21 AM
$ENTA anyone remember the dumb bastard on twitter who has his life savings and his customers heavily invested in this POS..what was his name..
0 · Reply
Jennx6
Jennx6 Jul. 21 at 10:06 PM
$ENTA news around the corner
0 · Reply
justiceforb_85
justiceforb_85 Jul. 15 at 7:19 PM
$ENTA adding on this dip. Will be a leader in the RSV anti-viral space.
0 · Reply
working_girl
working_girl Jul. 9 at 4:55 PM
$ENTA No news. Why is this POS cratering today?
1 · Reply
JarvisFlow
JarvisFlow Jul. 7 at 10:30 AM
JMP Securities updates rating for Enanta Pharma ( $ENTA ) to Market Outperform, target set at 21 → 23.
0 · Reply
justiceforb_85
justiceforb_85 Jul. 6 at 11:30 PM
$ENTA will be a leader in the RSV anti-viral space.
0 · Reply
Estimize
Estimize Jun. 25 at 7:05 PM
Wall St is expecting -0.84 EPS for $ENTA Q3 [Reporting 08/11 AMC] http://www.estimize.com/intro/enta?chart=historical&metric_name=eps&utm_c
0 · Reply